Oxcarbazepine Suspension
Product Images NDC 67877-532

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 67877-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine-1 (Oxcarbazepine 1)

Oxcarbazepine oral suspension cup container with a clear body and a white lid. The image shows a single-dose cup without visible text or labeling details. The container is commonly used for measuring and administering liquid medication.*

FDA Label Image

Oxcarbazepine-10 (Oxcarbazepine 10)

An instructional illustration showing a hand using a syringe to extract liquid from a bottle. The hand is rotating the syringe while inserted into the bottle's neck, indicating a mixing or drawing motion for the oral suspension medication.*

FDA Label Image

Oxcarbazepine-11 (Oxcarbazepine 11)

An instructional illustration depicting two steps of administering Oxcarbazepine oral suspension using a syringe. The first shows a person placing the syringe inside the mouth, and the second shows the syringe being rinsed or filled with liquid from a small cup.*

FDA Label Image

Oxcarbazepine-12 (Oxcarbazepine 12)

Chemical structure of oxcarbazepine, showing its molecular framework with fused rings and substituent groups.*

FDA Label Image

Oxcarbazepine-13 (Oxcarbazepine 13)

Kaplan-Meier plot comparing exit rates over a 9-day period starting from Day 2 for two groups: Oxcarbazepine treatment and placebo. The x-axis shows time in days and the y-axis shows exit rate. The plot includes a p-value indicating statistical significance (p=0.0001) from a log-rank test.*

FDA Label Image

Oxcarbazepine-14 (Oxcarbazepine 14)

A Kaplan-Meier plot showing seizure rate over time in days from the first dose to the first seizure. It compares two treatment groups: Oxcarbazepine and placebo, with seizure rates on the vertical axis and days on the horizontal axis. The plot includes a statistical significance indicator with a log-rank test p-value of 0.046.*

FDA Label Image

Oxcarbazepine-15 (Oxcarbazepine 15)

A Kaplan-Meier survival curve showing exit ratio over time to exit in days for two treatment groups labeled HIGH (solid line) and LOW (dashed line). The y-axis represents exit ratio from 0.0 to 1.0; the x-axis represents time to exit up to 130 days. A log-rank test p-value of 0.0001 is noted on the graph.*

FDA Label Image

Oxcarbazepine-16 (Oxcarbazepine 16)

A Kaplan-Meier plot chart illustrating the time to exit (in days) for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days, and the y-axis shows the exit rate, ranging from 0.0 to 1.0. The plot includes a log-rank test p-value of 0.0001, indicating a statistically significant difference between the groups over time.*

FDA Label Image

Oxcarbazepine-17-a (Oxcarbazepine 17 A)

Carton label for Oxcarbazepine Oral Suspension, USP 300 mg/5 mL (60 mg/mL data not shown), 250 mL bottle by Ascend Laboratories, LLC. The label includes directions to shake well before use, storage instructions, and states it is Rx only. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ.*

FDA Label Image

Oxcarbazepine-18-a (Oxcarbazepine 18 A)

Label for Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL bottle. The label includes storage instructions, pharmacist dispensing information, manufacturer (Alkem Laboratories, India) and distributor (Ascend Laboratories, LLC) details, and a barcode. It emphasizes shaking well before use and notes the product is for prescription use only.*

FDA Label Image

Oxcarbazepine-2 (Oxcarbazepine 2)

Oxcarbazepine 60 mg/mL oral suspension in a gray bottle with a black cap. The image shows the container without visible text or additional labeling. Manufactured by Ascend Laboratories, LLC.*

FDA Label Image

Oxcarbazepine-3 (Oxcarbazepine 3)

An instructional diagram of an oral syringe, labeled with volume markings from 1 mL to 10 mL. The parts labeled include the 'Barrel,' indicating the cylindrical body of the syringe, and the 'Plunger,' which is used to draw and dispense medication. The image is intended for accurate dosing of oral liquid medications.*

FDA Label Image

Oxcarbazepine-4 (Oxcarbazepine 4)

An instructional illustration showing a hand holding a suspension bottle and shaking it, with motion lines indicating the shaking action. This image visually demonstrates the proper way to shake an oral suspension medication bottle before use.*

FDA Label Image

Oxcarbazepine-5 (Oxcarbazepine 5)

An instructional diagram showing a person opening the cap of a bottle by pressing down and turning. The bottle is shaded gray and is likely a medication container, demonstrating how to remove the child-resistant cap safely.*

FDA Label Image

Oxcarbazepine-6 (Oxcarbazepine 6)

An illustration showing a hand holding a bottle of medication, shaking it side to side. The wavy lines near the bottle indicate the motion of shaking, demonstrating proper preparation of the oral suspension.*

FDA Label Image

Oxcarbazepine-7 (Oxcarbazepine 7)

An instructional illustration showing a hand holding a dosing syringe being inserted into the neck of a bottle containing liquid medication, demonstrating the method to draw oral suspension from the bottle for accurate dosing.*

FDA Label Image

Oxcarbazepine-8 New (Oxcarbazepine 8 New)

An instructional illustration showing a hand holding an oral syringe being filled from a bottle. The image focuses on demonstrating how to draw liquid medication into the syringe, indicated by a vertical arrow suggesting movement or adjustment.*

FDA Label Image

Oxcarbazepine-9 New (Oxcarbazepine 9 New)

An instructional illustration demonstrating proper technique to measure a liquid medication dose. It shows a dosing syringe being filled from a suspension bottle, with a close-up view of the syringe barrel marked with volume increments from 1 mL to 8 mL, highlighting the 6 mL dose level. A downward arrow indicates the action of drawing liquid into the syringe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.